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Abstract
Toll-like receptors (TLRs) and Nod-like receptors (NLRs) are known to trigger an innate immune response against microbial
infection. Although studies suggest that activation of TLRs modulate the function of mesenchymal stem cells (MSCs), little is
known about the role of NLRs on the MSC function. In this study, we investigated whether NOD1 and NOD2 regulate the
functions of human umbilical cord blood-derived MSCs (hUCB-MSCs). The genes of TLR2, TLR4, NOD1, and NOD2 were
expressed in hUCB-MSCs. Stimulation with each agonist (Pam3CSK4 for TLR2, LPS for TLR4, Tri-DAP for NOD1, and MDP for
NOD2) led to IL-8 production in hUCB-MSC, suggesting the expressed receptors are functional in hUCB-MSC. CCK-8 assay
revealed that none of agonist influenced proliferation of hUCB-MSCs. We next examined whether TLR and NLR agonists
affect osteogenic-, adipogenic-, and chondrogenic differentiation of hUCB-MSCs. Pam3CSK4 and Tri-DAP strongly enhanced
osteogenic differentiation and ERK phosphorylation in hUCB-MSCs, and LPS and MDP also slightly did. Treatment of U0126
(MEK1/2 inhibitor) restored osteogenic differentiation enhanced by Pam3CSK4. Tri-DAP and MDP inhibited adipogenic
differentiation of hUCB-MSCs, but Pam3CSK4 and LPS did not. On chondrogenic differentiation, all TLR and NLR agonists
could promote chondrogenesis of hUCB-MSCs with difference in the ability. Our findings suggest that NOD1 and NOD2 as
well as TLRs are involved in regulating the differentiation of MSCs.
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Introduction
Toll-like receptors (TLRs) are type I transmembrane proteins
and composed of extracellular leucine rich repeats (LRRs) domain
that are responsible for recognition of pathogen-associated
molecular patterns (PAMPs) and intracellular Toll/IL-1R (TIR)
domain, which is essential for downstream signaling. TLRs
recognize microbial molecules including lipoprotein (TLR2),
LPS (TLR4), flagellin (TLR5), dsRNA (TLR3), ssRNA (TLR7/
8), and CpG DNA motif (TLR9), and subsequently activate NF-
kB and MAPK to trigger inflammatory process [1]. In addition to
microbial molecules, a variety of endogenous agonists such as heat
shock proteins, high mobility group box 1 (HMGB1), hyaluronan
fragments, heparin sulphate, and fibronectin are recognized by
TLR2 or TLR4 [2].
As another PRRs family, Nod-like receptors (NLRs) are
intracellular, cytoplasmic sensor for microbial components and
danger signals [3,4]. There are 23 NLR family members in humans
and at least 34 genes in mice [4]. NLRs are expressed in
nonimmune cells including epithelial cells and mesothelial cells as
well as immune cells. As first identified NLRs, NOD1 and NOD2
consist of N-terminal caspase recruitment domain (CARD),
intermediate nucleotide-binding oligomerization domain (NOD),
and C-terminal leucine-rich repeats (LRRs) domain. NOD1 and
NOD2 recognize peptidoglycan (PGN) derivatives, meso-diamino-
pimelic acid (meso-DAP) and muramyl dipeptide (MDP), respec-
tively. After stimulation by their specific bacterial molecules, NOD1
and NOD2 associate with an adaptor molecule, RICK/Rip2/
CARDIAK, through CARD-CARD interaction, which leads to
activation of NF-kB and MAPK and induction of numerous genes
involved in inflammatory process [5,6].
Mesenchymal stem cells (MSCs) are multipotent adult progen-
itor cells that can differentiate to various cell types including
osteoblasts, adipocytes, chondrocytes, cardiomyocytes, fibroblasts,
and endothelial cells [7,8,9]. MSCs are thought to be excellent
candidate tools for the field of regenerative medicine, because of
their differentiation potential. In addition, MSCs were found to
suppress proliferation, differentiation, and activation of immune
cells including T cells, B cells, NK cells, and dendritic cells [10,11].
The isolation of MSCs have been described in several species
and from different tissues, including bone marrow (BM),
peripheral blood, adult fat, umbilical cord blood (UCB) and
skeletal muscle. Among MSCs, the most commonly used for
clinical purposes are isolated from BM or adipose tissue. Stem cells
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of newborn cells compared to adult cells. In our previous study, we
showed that hUCB-MSCs express OCT4A and REX1, a well-
known transcription factors that are characteristic markers of
pluripotent stem cells, and REX1 expression in hUCB-MSCs was
nearly five-fold greater than in hBM-MSCs [12,13]. Moreover,
hUCB-MSCs provide no ethical barriers for basic studies and
clinical applications [14,15].
Recent studies showed that TLRs regulate MSCs functions such
as proliferation, differentiation, migration, and immunomodula-
tion [16,17,18]. Although van den Berk et al [19], recently
reported the involvement of TLRs in the regulation of the
functions of cord blood MSCs, most studies have focused on BM-
or adipose tissue-derived MSCs (ASC). In addition, little is known
about the role of NLRs on MSCs functions. This study was
performed to clarify the role of NOD1 and NOD2 on the
proliferation and differentiation of hUCB-MSCs. We show here
that NOD1 and NOD2 as well as TLRs are involved in regulating
the differentiation of hUCB-MSC.
Materials and Methods
Isolation and culture of hUCB–MSCs
The UCB samples were obtained from the umbilical vein
immediately after delivery, with the written informed consent of
the mother approved by the Boramae Hospital Institutional
Review Board (IRB) and the Seoul National University IRB(IRB
No. 0603/001-002-07C1). The UCB samples were mixed with the
Hetasep solution (StemCell Technologies, Vancouver, Canada) at
a ratio of 5:1, and then incubated at room temperature to deplete
erythrocyte counts. The supernatant was carefully collected and
mononuclear cells were obtained using Ficoll density-gradient
centrifugation at 2,500 rpm for 20 min. The cells were washed
twice in PBS. Cells were seeded at a density of 2610
5 to 2610
6
cells/cm
2 on plates in growth media consisted of D-media
(Formula No. 78-5470EF, Gibco BRL) containing EGM-2
SingleQuot and 10% fetal bovine serum (Gibco BRL). After 3
days, non-adherent cells were removed. The adherent cells formed
colonies and grew rapidly, exhibiting spindle-shaped morphology.
Reagents
Ultrapure LPS (E. coli O111:B4), Pam3CSK4, and Tri-DAP
were purchased from Invivogen (San Diego, CA, USA). MDP [Ac-
(6-O-stearoyl)-muramyl-Ala-D-Glu-NH2] was from Bachem (Bu-
bendorf, Switzerland). MEK1/2 Inhibitor U0126 was from
Promega (Madison, WI, USA).
Flow cytometric analysis
hUCB-MSCs(1610
6/ml) were stained with FITC- or PE-
conjugated antibodies specific for human CD14, CD29, CD31,
CD33, CD34, CD44, CD45, CD73, CD90, CD105, CD133, and
HLA-DR. Non-specific isotype-matched antibodies served as
controls. All the antibodies were purchased from BD Bioscience,
and flow cytometry analysis was performed on a FACSCaliber
using the Cell Quest software (Becton Dickinson, Franklin Lakes,
NJ, USA).
RNA extraction and RT-PCR
Total RNA was extracted from hUCB-MSCs by using Easy-
spin total RNA extraction kit (Intron Biotechnology, Seongnam,
Korea) according to the manufacture’s protocol. cDNA was
prepared from 1 mg of total RNA by using Superscript III reverse
transcriptase (Invitrogen, Carlsbad, CA, USA) and oligo (dT)
primers (Invitrogen). The primer sets used were as follows;
TLR2, F: 59- GATGCCTACTGGGTGGAGAA-39,R :5 9-
CGCAGCTCTCAGATTTACCC-39
TLR4, F: 59- ACAGAAGCTGGTGGCTGTG-39,R :5 9-
TCTTTAAATGCACCTGGTTGG-39
NOD1, F: 59- CCACTTCACAGCTGGAGACA-39,R :5 9-
TGAGTGGAAGCAGCATTTTG-39
NOD2, F: 59- GAATGTTGGGCACCTCAAGT-39,R :5 9-
CAAGGAGCTTAGCCATGGAG-39
Rip2, F: 59- CCATTGAGATTTCGCATCCT-39,R :5 9-
ATGCGCCACTTTGATAAACC-39
RPL13A, F: 59- CATCGTGGCTAAACAGGTAC-39,R :5 9-
GCACGACCTTGAGGGCAGCC-39
The PCR condition consisted of an initial denaturation at 95uC
for 3 min; 30 cycles of 94uC for 30 sec, 60uC for 30 sec and 72uC
for 1 min; a final extension at 72uC for 10 min. The PCR
products were separated on a 1.5% agarose gel, visualized, and
photographed using a gel documentation system.
Cytokine production
Briefly, hUCB-MSCs (2610
4/well) were seeded in MSC
medium supplemented with 2% FBS in 96-well plate. Twenty-
four hours later, the cells were treated with various doses of
Pam3CSK4, LPS, Tri-DAP, and MDP and incubated for
additional 24 h. Culture supernatant was collected, centrifuged,
filtered through 0.2 mm filter and IL-8 concentration was
measured using commercial ELISA kit (R&D Systems, Minnea-
polis, MN, USA) according to manufacturer’s protocol.
hUCB-MSC proliferation
The cells were seeded at 2610
3/well in 96-well plates in MSC
medium supplemented with 2% FBS. Twenty-four hours later, the
cells were treated with Pam3CSK4, LPS, Tri-DAP, and MDP at
10 mg/ml concentration and incubated for 4 days. Proliferation
was determined by Cell Counting Kit-8 (Dojindo Molecular
Technologies, Rockville, MD, USA) according to manufacturer’s
instruction.
hUCB-MSC differentiation
Osteogenic differentiation. The cells were incubated in
conditioned media containing DMEM low glucose medium, 10%
FBS, 0.1 mM dexamethasone, 10 mM beta-glycerophosphate, and
50 mM ascorbate at the absence or presence of TLR and NLR
agonists. The cells were grown for 2 weeks, with medium
replacement twice a week. Osteogenesis was detected by Alizarin
Red staining. Photographs were taken and optical density was
measured at 570 nm.
Adipogenic differentiation. The cells were incubated in
conditioned media containing DMEM low glucose medium, 10%
FBS, 1 M dexamethasone, 10 mg/ml insulin, 0.5 mM 3-isobutyl-
1-methylxanthine, and 0.2 mM indomethacin at the absence or
presence TLR and NLR agonists. The cells were grown for 3
weeks, with media replacement twice a week. Adiopogenesis was
detected by Oil red O staining. Photographs were taken and
optical density was measured at 500 nm.
Chondrogenic differentiation. 2610
5 cells were seeded in
15-mL polypropylene tube and centrifuged to a pellets. The pellets
were cultured in 1 ml of chondrogenic medium that contained
10% FBS and 500 ng/ml bone morphogenetic protein-2(BMP-2;
R&D Systems) for 3 weeks. The chondrogenic differentiation
medium was replaced twice a week. The pellets were embedded in
paraffin and cut into 3 mm sections. For histological evaluation,
the sections were stained with toluidine blue following general
procedures.
Role of NLR and TLR in hUCB-MSCs function
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The cells were stimulated with agonists, harvested, and lysed in
buffer containing 1% Nonidet-P40 supplemented with complete
protease inhibitor ‘cocktail’ (Roche) and 2 mM dithiothreitol.
Lysates were resolved by 12% SDS-PAGE, transferred to
nitrocellulose membranes, and immunoblotted with primary
antibodies such as regular- and phopho-ERK (Cell signaling,
Beverly, MA, USA) and GAPDH (Santa Cruz biotechnology,
Santa Cruz, CA, USA). After immunoblotting with secondary
antibodies, proteins were detected with enhanced chemilumines-
cence (ECL) reagent (Intron Biotechnology).
Statistical analysis
The differences in mean values among different groups were
tested, and the values were expressed as mean 6 SD. All of the
statistical calculations were calculated by one-way ANOVA
followed by Bonferroni post-hoc test for multigroup comparisons
(StatView 5.0; SAS Institute, Cary, NC). Statistical significance is
indicated in the figure legends.
Results
TLR2, TLR4, NOD1, and NOD2 were functionally
expressed in hUCB-MSCs
To verify the stem cell phenotypic markers of hUCB-MSCs using
flow cytometry, we observed that hUCB-MSCs were negative for
CD14, CD31, CD33, CD34, CD45, CD133 and HLA-DR
expression but positive for CD29, CD44, CD73, CD90 and
CD105 (data not shown). The gene expression of TLR2, TLR4,
NOD1, and NOD2 in hUCB-MSCs was examined by RT-PCR. A
human monocytic leukemia cell line, THP-1 cells were used as
positive control. All receptors tested were expressed in both THP-1
cells and hUCB-MSCs (Fig. 1A). TLR4 was expressed more strongly
in hUCB-MSCs than in THP-1 cells, whereas the gene expression of
TLR2, NOD1, and NOD2 was weaker in UCB-MSC (Fig. 1A).
Rip2, the adaptor protein of NOD1 and NOD2, was also apparently
expressed in hUCB-MSCs (Fig. 1A). To evaluate the functionality of
the receptors, we examined IL-8 production by hUCB-MSCs in
response to their specific agonists. Stimulation by Pam3CSK4 (TLR2
agonist), LPS (TLR4), Tri-DAP (NOD1), and MDP (NOD2) led to
increased production of IL-8 in hUCB-MSCs in a dose-dependent
manner (Fig. 1B and C). These findings indicate that NOD1 and
NOD2, as well as TLR2 and TLR4, are expressed in hUCB-MSCs
and can respond to their specific agonists.
Activation of TLRs and NLRs did not influence the
proliferation of hUCB-MSCs
TLRs have been found to promote the proliferation of several
types of MSC [17,20,21]. To examine whether TLR and NLR
activation influence the proliferation of hUCB-MSC, the cells
were incubated at the absence or presence of each agonist
(Pam3CSK4, LPS, Tri-DAP, and MDP) for 4 days and cell
proliferation was determined by CCK-8 analysis. Results showed
that none of agonists influenced the proliferation of hUCB-MSC
(Fig. 2A and B).
Activation of TLRs and NLRs promoted osteogenic
differentiation of hUCB-MSCs
It has been shown that TLRs modulates the differentiation of
MSCs [16,17]. To determine whether TLRs and NLRs are
involved in osteogenic differentiation of hUCB-MSCs, the cells
were treated with Pam3CSK4, LPS, Tri-DAP, and MDP and
cultured in standard osteogenic medium. During osteogenic
differentiation of two different hUCB-MSCs (#618 and #1114),
all agonists tested significantly induced higher intensity of the
Alizarin red S staining (Fig. 3A and B). It has shown that
extracellular signal-regulated protein kinases (ERK) activation
plays an important role in the osteogenic differentiation of MSCs
[22]. Therefore, we explored whether TLR and NLR agonists
lead to ERK activation in hUCB-MSCs. As expected, stimulation
by TLR and NLR agonists rapidly induced phosphorylation of
ERK in hUCB-MSCs (Fig. 3C). To determine whether inhibition
of ERK is associated with osteogenic differentiation of hUCB-
MSCs, the Pam3CSK4-stimulated cells were treated with U0126
as an MEK1/2 inhibitor. In Alizarin Red S staining, treatment of
U0126 restored osteogenic differentiation of hUCB-MSCs en-
hanced by Pam3CSK4 (Fig. 3D and E). These results indicated
that both TLR and NLR signaling may promote osteogenic
differentiation of hUCB-MSCs through ERK-dependent pathway.
Tri-DAP and MDP, but not Pam3CSK4 and LPS, inhibited
adipogenic differentiation of hUCB-MSCs
To determine the effects of TLR and NLR agonists on
adipogenic differentiation of hUCB-MSCs, the cells were incubated
at the absence or presence of each agonist for 3 weeks. As shown in
Fig. 4A–C, stimulation with Tri-DAP and MDP significantly
inhibited adipogenic differentiation at 3 weeks after treatment,
whereas Pam3CSK4 and LPS did not influence on adipogenic
differentiation of hUCB-MSCs (Fig. 4A–C). This phenomenon was
Figure 1. TLRs and NLRs were functionally expressed in hUCB-MSCs. mRNA expressions of TLR2, TLR4, NOD1, NOD2, and Rip2 were
determined by RT-PCR in hUCB-MSCs (A). The cells were treated with Pam3CSK4, LPS (B), Tri-DAP, and MDP (C) in a dose-dependent manner for 24 h
and IL-8 production was determined using a commercial ELISA kit (B and C).
doi:10.1371/journal.pone.0015369.g001
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Pam3CSK4, LPS (A), Tri-DAP, and MDP (B) for 4 days and cell proliferation was determined by CCK-8 kit.
doi:10.1371/journal.pone.0015369.g002
Figure 3. Stimulation with TLR and NLR agonists promoted osteogenic differentiation of hUCB-MSCs through phosphorylation or
ERK1/2. hUCB-MSCs were grown in conditioned media at the absence or presence of Pam3CSK4, LPS, Tri-DAP, and MDP (10 mg/ml) for 2 weeks, and
culture media was replaced twice per week. Osteogenesis was determined by Alizarin Red S at 2 weeks after treatment (A) and optical density was
determined using ELISA at 570 nm (B). hUCB-MSCs were treated with Pam3CSK4, LPS, Tri-DAP, and MDP for 15, 30, and 60 min and ERK
phosphorylation was determined by Western Blot analysis with an anti-phospho-ERK antibody (C). hUCB-MSCs were co-treated with Pam3CSK4 and
U0126 for 2 weeks and determined by Alizarin Red staining (D) and quantified using ELISA at 570 nm (E). * P,0.05, ** P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0015369.g003
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These findings suggest that NOD1 and NOD2 signaling may be
involved in adipogenic differentiation of hUCB-MSCs.
Enhanced chondrogenic differentiation of hUCB-MSCs by
TLR and NLR agonists
To determine whether TLR and NLRs are involved in
chondrogenic differentiation of hUCB-MSCs, hUCB-MSCs were
maintained in BMP-2 supplemented chondrogenic medium at the
absence or presence of each agonists. All TLR and NLR agonists
used increased the diameter of pellets (Fig. 5A). All the pellets were
positive to toluidine blue staining (Fig. 5B). These data suggest that
both TLR and NLR signaling may be involved in chondrogenesis
of hUCB-MSCs.
Discussion
NLRs have been found to be involved in cytosolic recognition of
microbial molecules such as PGN derivatives (by NOD1 and
NOD2) and flagellin (by NLRC4/IPAF) [3]. Similarly with TLR
signaling, NOD1 and NOD2 trigger inflammatory response
through activation of NF-kB and MAPK. Moreover, NOD1
and NOD2 agonists, in combination with TLR agonists,
synergistically induce cytokine production and activation of NF-
kB and MAPK in immune cells [23,24,25]. These findings suggest
Figure 4. Tri-DAP and MDP inhibited adipogenic differentiation of hUCB-MSCs. hUCB-MSCs were grown in conditioned media at the
absence or presence of Pam3CSK4, LPS, Tri-DAP, and MDP (10 mg/ml) for 3 weeks, and culture media was replaced twice per week. Adipogenesis was
determined by Oil Red O staining (A) and level of intercellular lipid was determined using ELISA at 500 nm at 3 weeks after treatment (B and C). hUCB-
MSCs (#1114) from another umbilical cord blood were grown in conditioned media at the absence or presence of each ligands for 3 weeks, and
adipogenesis was determined (D) and quantified using ELISA at 500 nm (E). ** P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0015369.g004
Figure 5. Activation of TLRs and NLRs promoted chondrogenic differentiation of hUCB-MSCs. hUCB-MSCs were prepared as pellets and
they were cultured in chondrogenic medium supplemented with 500 ng/ml BMP-2 for 3 weeks. Then, the volume of pellets was measured (A) and
stained with toluidine blue (B). * P,0.05.
doi:10.1371/journal.pone.0015369.g005
Role of NLR and TLR in hUCB-MSCs function
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events. As TLRs modulate the functions of a variety of MSCs, in
this study, we explored the role of NLRs, particularly NOD1 and
NOD2, on hUCB-MSCs function. In addition, because most
studies about the role of TLRs have been performed in BM- or
adipose tissue-derived MSCs, we also confirmed the effect of
TLR2 and TLR4 on UCB-MSC functions.
A previous study showed that cord blood MSCs expressed low
levels of TLR1, 3, 5, 9 and high level of TLR4 [19]. However, in
our study, both TLR2 and TLR4 were expressed in hUCB-MSCs,
although TLR4 expression was much stronger than TLR2. This
discrepancy might be due to difference of PCR condition used or
MSCs origin. Many studies also showed functional expression of
TLR2 in BM- or adipose tissue-derived MSCs (ASC) [16,17,18,26].
Moreover,inthisstudy,Pam3CSK4andLPSstimulationled toIL-8
production in UCB-MSC, suggesting that hUCB-MSCs function-
ally express TLR2 and TLR4.
It has been known that NOD1 is ubiquitously expressed in a
variety of cell types, whereas NOD2 is mainly expressed in immune
cells [27]. In this study, the genes of NOD1 and NOD2 were
apparently expressed in hUCB-MSCs, although expression levels
were relatively weaker than those of TLR2 and TLR4. In addition,
mRNAofRip2/RICK, anadaptor molecule ofNOD1 andNOD2,
was also expressed. Stimulation with Tri-DAP and MDP, NOD1
and NOD2 agonists, led to IL-8 production, indicating the
functional expression of NOD1 and NOD2 in hUCB-MSCs.
There are discrepancies about the effect of TLRs on the MSC
proliferation. A recent study showed that TLR agonists including
PGN, LPS, poly I:C, and flagellin did not affect the proliferation
of human ASC (hASC) [16]. Only CpG-ODN, TLR9 agonists,
reduced slightly hASC proliferation [16]. This was confirmed by
a study of Lombardo et al. [26], showing that TLR3 and TLR4
agonists had no effect on the proliferation of hASCs. In contrast,
downregulation of MyD88, a common adaptor molecule for
TLRs except TLR3, using siRNA inhibited the proliferation of
hASC [21]. In addition, TLR agonists such as Pam3Cys and LPS
enhanced the proliferation of mouse BM-MSCs [17,20],
suggesting involvement of TLRs on MSC proliferation. Collec-
tively, these results indicate that the effect of TLRs on MSC
proliferation may be a cell-type specific event. In our study, the
agonistsofNOD1 and NOD2 aswellas TLR2 and TLR4 did not
influence hUCB-MSCs proliferation. It is needed to clarify the
effect of NOD1 and NOD2 on the proliferation of different types
of MSCs.
It has been well known that TLRs are associated with MSC
differentiation. Particularly, TLRs seem to be involved in
osteogenic rather than adipogenic differentiation of MSC. TLR3
and TLR4 agonists significantly increased osteogenic differentia-
tion of hASCs, but did not affect adipogenic differentiation
[21,26]. Other TLR agonists (poly I:C, flagellin, CpG-ODN) also
did not influence adipogenic differentiation of hASC [16].
Interestingly, PGN inhibited adipogenic differentiation of hASCs
significantly [16,21]. In those studies, PGN was used as TLR2
agonist. However, a previous study by Travassos et al. [28]
revealed that highly purified PGN was not detected by TLR2.
They suggested that cell wall contaminants such as lipoteichoic
acid (LTA) or lipoproteins present in PGN preparations are
responsible for TLR2-dependent cell activation [28]. In our study,
Tri-DAP and MDP significantly inhibited adipogenic differentia-
tion of hUCB-MSCs at 2 and 4 weeks after stimulation, whereas
Pam3CSK4 and LPS did not, suggesting involvement of NOD1
and NOD2 on adipogenic differentiation of hUCB-MSCs. As well
known, NOD1 and NOD2 recognize PGN derivatives, meso-DAP
and MDP, respectively. Accordingly, it is likely that NOD1 and
NOD2 are involved in PGN-mediated inhibition of adipogenic
differentiation of hASCs. It should be clarified the role of TLR2 on
adipogenic differentiation of MSC and which receptor originally
mediates inhibitory effect of PGN. In addition, various TLR
agonists enhance osteogenic differentiation of MSCs [16,21,26].
Our results showed that all TLR and NLR agonists used increased
osteogenic differentiation of hUCB-MSCs, suggesting that NLRs
as well as TLRs may be involved in osteogenic differentiation of
MSCs. ERK phosphorylation is correlated with the osteogenic
differentiation of MSCs [22,29]. Because TLR and NLR agonists
enhanced osteogenic differentiation of hUCB-MSCs, we examined
ERK phosphorylation by the agonists. LPS and MDP induced
ERK phosphorylation within 1 h in mouse macrophages [24,30].
In this study, Pam3CSK4 and MDP induced ERK phosphoryla-
tion in hUCB-MSCs from 15 min after treatment and the level
reached to peak at 30 min post-treatment. LPS and Tri-DAP
induced ERK phosphorylation from 30 min post-treatment. ERK
was strongly phosphorylated in the hUCB-MSCs treated with
Pam3CSK4, whereas LPS induced only mild activation of ERK,
which correlated with intensity of Alizarin Red S staining.
Moreover, U0126, MEK1/2 inhibitor, inhibited osteogenic
differentiation enhanced by Pam3CSK4. Taken together, it is
likely that ERK signaling is critical for osteogenic differentiation of
hUCB-MSCs induced by TLR and NLR stimulation.
In our knowledge, there is no report about the effect of TLRs on
chondrogenic differentiation of MSCs, except the study by
Pevsner-Fischer et al [17]. They revealed that TLR2 stimulation
with Pam3Cys inhibited induced differentiation of MSCs into
osteogenic, adipogenic, or chondrogenic lineages. However, in this
study, all used agonists including Pam3CSK4 enhanced the
chondrogenic differentiation potential of hUCB-MSCs. The
reason for this discrepancy remains to be elucidated.
In conclusion, the present study revealed novel information that
NOD1 and NOD2 as well as TLRs are involved in regulating the
differentiation of hUCB-MSCs. These findings are expected to
provide better understanding of the biological function of MSCs.
Further study using in vivo model is need to clarify physiological
role of NOD1 and NOD2 on MSC functions.
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